Projecting the long‐term societal value of a disease‐modifying treatment for Alzheimer's disease in the United States

Abstract

With a total of $5.5 trillion, the projected gross societal value of a hypothetical AD treatment is substantial, which may help to put the cost of treatment into perspective.